SOLTF (Nxera Pharma Co) Net Income (Continuing Operations) : $-14.4 Mil (TTM As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Nxera Pharma Co's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was $-5.1 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was $-14.4 Mil.

Nxera Pharma Co Net Income (Continuing Operations) Historical Data

The historical data trend for Nxera Pharma Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Net Income (Continuing Operations) Chart

Nxera Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

14.25

8.93

2.83

-49.96

-31.45

Nxera Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-21.90	-9.01	8.39	-8.68	-5.10

Nxera Pharma Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.4 Mil.

Nxera Pharma Co (OTCPK:SOLTF) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Nxera Pharma Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

4565:Japan

Address

Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website

https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).